One hundred eight fellow untreated eyes of 143 patients with GA resulting from AMD enrolled in the MAHALO study ( clinicaltrials.gov identifier , NCT01229215 ) who completely satisfied the study term and had gradable spectral-domain optical coherence tomography ( OCT ) images obtained at both baseline and month 18 visits .